Michael Batey
Michael Batey
I am a preclinical scientist and a senior business development manager at Waters. I have more than 18 years of experience in drug discovery, both in academia and industry with a major focus in oncology. In recent years, I have developed a passion for developing novel preclinical in vivo models that offer better clinical translation, specifically utilizing new techniques in imaging (MRI, CT, Optical Imaging, MS Imaging). Specialties: Preclinical studies; in vivo imaging including optical imaging, PET/CT and MRI; new model development; clinically relevant PD markers; oncology drug development.

Posts by author

Do You See What We See? Mass Spectrometry Imaging is Revealing Insights in Biomedical Research

By June 21, 2016

The spatial distribution of molecular species in a sample can provide a wealth of information about biological, chemical and physiological processes. Mass spectrometry (MS) imaging is a rapidly developing research technique that enables specific measurement… Read more >

Categories: Health Sciences

Molecular Visualization: Mass Spec Imaging Delivers Insights for Cancer Research

By April 16, 2016

How does mass spectrometry (MS) imaging provide a molecular image that can be used for the biochemical characterization of histological images? A rapidly developing technique for clinical research, MS imaging enables investigation of the spatial… Read more >

Categories: Health Sciences
Tags: , ,